Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 24 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 24, 2023, titled "Zydus receives final approval from the USFDA for Zinc Sulfate Injection USP, 10 mg/10 mL (1 mg/mL), 30 mg/10 mL (3 mg/mL), and 25 mg/5 mL (5 mg/mL) Pharmacy Bulk Package Vials".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases